Q4 2024 · 13F-HR
Avidity Partners Management LPholdings as filed
Filed 2025-02-14 · accession 0001791827-25-000002
$1.02B
Reported value
63
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $62.6M | 6.15% | 2,873,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $46.0M | 4.52% | 515,000 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $39.7M | 3.90% | 741,900 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $35.4M | 3.48% | 223,800 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $33.9M | 3.33% | 603,011 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $33.8M | 3.32% | 64,800 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $31.5M | 3.09% | 1,097,800 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $30.4M | 2.98% | 60,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $30.1M | 2.95% | 220,400 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $29.0M | 2.84% | 1,126,700 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $28.9M | 2.84% | 234,500 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $27.5M | 2.71% | 666,200 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY IN | $26.1M | 2.56% | 658,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $26.0M | 2.56% | 1,358,000 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $25.5M | 2.50% | 170,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $24.7M | 2.43% | 318,000 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $23.2M | 2.28% | 44,600 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $22.6M | 2.22% | 89,200 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $20.1M | 1.98% | 500,000 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $20.0M | 1.96% | 947,000 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $19.8M | 1.95% | 1,500,000 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $19.5M | 1.92% | 1,165,800 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $19.5M | 1.92% | 446,200 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $18.6M | 1.82% | 474,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $17.3M | 1.70% | 137,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $16.1M | 1.58% | 232,800 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $15.9M | 1.56% | 188,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $15.4M | 1.51% | 176,600 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $15.4M | 1.51% | 67,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $14.8M | 1.45% | 352,000 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $14.7M | 1.44% | 109,700 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $14.3M | 1.41% | 80,700 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $13.4M | 1.32% | 700,000 | CALL | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $13.2M | 1.30% | 1,053,300 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $12.2M | 1.19% | 215,000 | Common | SOLE |
| 89377M109 | TMDX | TRANSMEDICS GROUP INC | $12.0M | 1.18% | 192,400 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $11.3M | 1.11% | 1,390,100 | Common | SOLE |
| 86881A100 | SGRY | SURGERY PARTNERS INC | $10.9M | 1.07% | 514,200 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $10.2M | 1.00% | 1,265,200 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $9.1M | 0.89% | 354,000 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $9.0M | 0.88% | 129,600 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $8.6M | 0.84% | 2,694,600 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $8.5M | 0.84% | 62,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $8.3M | 0.82% | 222,900 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $8.1M | 0.80% | 97,000 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $8.0M | 0.78% | 7,966,400 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $7.9M | 0.77% | 7,477,200 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $6.8M | 0.67% | 352,124 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $6.0M | 0.59% | 8,400 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $4.5M | 0.44% | 76,300 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $4.2M | 0.42% | 100,000 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $4.1M | 0.40% | 532,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $3.9M | 0.39% | 222,000 | Common | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $3.4M | 0.33% | 502,600 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $3.3M | 0.33% | 210,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $2.3M | 0.22% | 82,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $2.3M | 0.22% | 96,000 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $2.2M | 0.22% | 287,104 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $1.6M | 0.16% | 150,000 | CALL | SOLE |
| 811292200 | SCYX | SCYNEXIS INC | $1.5M | 0.15% | 1,228,910 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $1.4M | 0.13% | 2,018,500 | Common | SOLE |
| 44916K106 | HYPR | HYPERFINE INC | $1.0M | 0.10% | 1,188,178 | Common | SOLE |
| 09609G209 | BLE0 | BLUEBIRD BIO INC | $680,169 | 0.07% | 81,555 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.